India's TDB is supporting Helix Cell Therapeutics to develop an affordable, dual-targeting CAR-T therapy for multiple myeloma, aiming to improve treatment outcomes via Indo-Singapore collaboration.

As the cosmetics industry continues to pursue more sustainable, high-performance, and biotechnology-driven ingredients, plant ...

Perth biotech Syngenis is using artificial intelligence to slash the time and cost of discovering RNA therapies and ...

Engineered microorganisms are widely used in industrial biotechnology and biopharmaceutical applications, including the ...

Jitendra Singh, Minister of State, emphasizes the role of technology in enhancing resilience and preparedness during National ...

Zymeworks Inc. (Nasdaq: ZYME), a biotechnology company managing a portfolio of licensed healthcare assets while developing a ...

Pakistan is looking to expand exports of elite buffalo embryos and dairy genetics to China as the country seeks new ...

WORK Medical is pushing deeper into AI-driven healthcare and digital biological asset development through a new collaboration ...

China behind only US and UK in ranking, reflecting the country’s ‘major scale’ in AI, biotechnology and talent, says Deep ...

Federal University of Allied Health Sciences, Enugu, unveils 27 new academic programmes including AI, Biotechnology, and ...

The clinic will provide guidance on regulatory approvals, clinical validation, licensing and commercialisation of medical ...